Loading...
Thumbnail Image
Publication

Co-presence of Epstein-Barr Virus and Human Papillomavirus is associated with a high frequency of p53 gene mutation in cervical cancer diagnosed in southern Nigeria

Eze, Ukpai A.
Okoye, Jude
Ngokere, Anthony
Onyenekwe, Chinedum
Uduchi, Immaculata
Advisors
Editors
Other Contributors
EPub Date
Publication Date
2023-12-01
Submitted Date
Other Titles
Abstract
Background: Evidence shows that the co-existence of Human papillomavirus (HPV) and Epstein-Barr virus (EBV) is associated with aggressive and poorly differentiated cervical squamous cell carcinomas (CSCC) phenotype. Aim: This study aimed to determine the frequency of mutant p53 (mtp53) gene in single and co-existence of HPV and oncogenic EBV latent membrane protein 1 (E-LMP1) among women diagnosed with CSCC in Southern Nigeria. Methods: This retrospective cohort study included 105 cervical cancer tissues, diagnosed between January 2016 and December 2018. The tissue sections were immunohistochemically stained for mtp53, E-LMP1, and HPV proteins and scored accordingly. Descriptive, Chi- square test and Pearson’s correlation were performed, and statistical significance was set at p≤0.05. Result: Among the stained sections, the frequency of HPV, E-LMP1, and E-LMP1/HPV detection was 8.6%, 20.0%, and 42.9%, respectively. The mtp53 detection was higher in ELMP1/HPV co-presence (86.7%) compared with HPV and ELMP1 mono-presence (55.6%, and 14.3%, respectively), and this was statistically significant (p< 0.0001). The prevalence of invasive and non-invasive cases of CSCC were 62.9% and 37.1%, respectively. E-LMP1 and HPV co-presence were significantly higher in invasive cervical cancer (48.5%) compared to non-invasive cervical cancer cases (33.3%) at p= 0.156. The E-LMP1 presence was significantly higher in poorly differentiated CSCC (50.0%) compared to the moderately and well- differentiated CSCC (25.0% and 10.5%, respectively) at p= 0.011. Conclusion: This study revealed a higher frequency of EBV/HPV co- infection in CSCC. It also shown- that a higher frequency of mtp53 in E-LMP1 and HPV co-presence, suggesting that E-LMP1 could be responsible for the high CSCC lethality in West Africa.
Citation
Eze, U. A., Okoye, J., Ngokere, A., Onyenekwe, C., & Uduchi, I. (2023). Co-presence of Epstein-Barr Virus and Human Papillomavirus is associated with a high frequency of p53 gene mutation in cervical cancer diagnosed in southern Nigeria. Bayero Journal of Medical Laboratory Science, 8(2), 27-33.
Publisher
Department of Medical Laboratory Science of Bayero University
Journal
Bayero Journal of Medical Laboratory Science
Research Unit
DOI
PubMed ID
PubMed Central ID
Type
Article
Language
Description
Series/Report no.
ISSN
2545-5672
EISSN
2635-3792
ISBN
ISMN
Gov't Doc
Test Link
Sponsors
Unfunded
Additional Links
https://www.ajol.info/index.php/bjmls/article/view/261419